Allworth Financial’s Mereo BioPharma MREO Stock Holding History

Allworth Financial’s Portfolio MREO Stock Details MREO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$477	Hold	1,500	–	–	﹤0.01%	4858
2026 Q1	$495	Sell	1,500 -111	-7%	-$48	﹤0.01%	4731
2025 Q4	$672	Buy	1,611 +38	+2%	+$72	﹤0.01%	4465
2025 Q3	$3.24K	Sell	1,573 -64	-4%	-$118	﹤0.01%	3786
2025 Q2	$4.44K	Buy	1,637 +137	+9%	+$331	﹤0.01%	3328
2025 Q1	$3.81K	Hold	1,500	–	–	﹤0.01%	2907
2024 Q4	$4.38K	Hold	1,500	–	–	﹤0.01%	2826
2024 Q3	$6.17K	Hold	1,500	–	–	﹤0.01%	2476
2024 Q2	$5.82K	Hold	1,500	–	–	﹤0.01%	2452
2024 Q1	$4.95K	Hold	1,500	–	–	﹤0.01%	2412
2023 Q4	$3.46K	Hold	1,500	–	–	﹤0.01%	2432
2023 Q3	$1.94K	Hold	1,500	–	–	﹤0.01%	2556
2023 Q2	$1.98K	Hold	1,500	–	–	﹤0.01%	2489
2023 Q1	$1.06K	Hold	1,500	–	–	﹤0.01%	2649
2022 Q4	$1.13K	Buy	+1,500	New	+$1.23K	﹤0.01%	2436

Other funds holding MREO

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

DCM

Defilade Capital Management Emeryville, California $747M AUM

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Allworth Financial's MREO Position: Q2 2026 in Review

Allworth Financial held its Mereo BioPharma (MREO) position steady in Q2 2026 at 1,500 shares worth $477. The position accounts for ﹤0.01% of the portfolio, ranked #4858.

Allworth Financial first reported a position in MREO in Q4 2022 and has held it in 15 quarters since. The position peaked at $6.17K in Q3 2024. 60 funds tracked by Wall St. Rank hold MREO as of Q2 2026.

Allworth Financial held 1,500 shares of Mereo BioPharma worth $477 as of Q2 2026.
Allworth Financial left its Mereo BioPharma share count unchanged in Q2 2026.
Mereo BioPharma made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4858 holding.
Allworth Financial first reported a position in Mereo BioPharma in Q4 2022 and has held it in 15 quarters since.
Allworth Financial's Mereo BioPharma position peaked at $6.17K in Q3 2024.
60 funds tracked by Wall St. Rank held Mereo BioPharma as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.